Besides, LYN was enriched in CL and ME subtype of gliomas, which indicated worse survival, and LYN was associated with 1p19q non-codeletion and unmethylated MGMT promoter, both of which predicted worse survival in glioma patients. Here, MGMT is linked to central nervous system cancer.